TGA

Dementia drug rejected by TGA

The Therapeutic Goods Administration (TGA) has decided not to register Alzheimer's drug lecanemab (LEQEMBI) on the basis that "the demonstrated…

FDA approves drug for early symptomatic Alzheimer’s disease

The U.S. Food and Drug Administration (FDA) has approved the Kisunla (donanemab-azbt) injection for the treatment of Alzheimer’s disease after months of…